Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EYE National Vision	$23.00 +2.9%	$16.88	$9.56 ▼ $23.22	$1.82B	1.24	1.89 million shs	2.61 million shs
RXST RxSight	$13.87 +2.7%	$14.76	$12.53 ▼ $60.81	$563.64M	1.29	706,783 shs	594,609 shs
STAA STAAR Surgical	$16.85 +1.3%	$17.93	$13.50 ▼ $49.86	$834.52M	0.63	852,125 shs	971,050 shs
WRBY Warby Parker	$21.34 -2.3%	$18.38	$12.46 ▼ $28.68	$2.23B	2.1	1.96 million shs	1.83 million shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EYE National Vision	0.00%	+7.63%	+18.68%	+76.65%	+77.20%
RXST RxSight	0.00%	-2.80%	-16.55%	-44.16%	-75.70%
STAA STAAR Surgical	0.00%	-3.38%	-12.42%	-4.91%	-59.13%
WRBY Warby Parker	0.00%	-4.70%	+4.49%	+13.25%	+38.82%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EYE National Vision	3.1733 of 5 stars	2.2	4.0	3.3	2.8	0.8	0.0
RXST RxSight	2.8821 of 5 stars	4.2	2.0	0.0	2.2	1.7	0.6
STAA STAAR Surgical	4.1672 of 5 stars	3.0	2.0	4.1	3.2	3.3	0.6
WRBY Warby Parker	2.0957 of 5 stars	2.3	2.0	0.0	3.3	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EYE National Vision	2.44	Hold	$18.67	-18.84% Downside
RXST RxSight	2.30	Hold	$37.90	173.25% Upside
STAA STAAR Surgical	2.00	Hold	$24.63	46.14% Upside
WRBY Warby Parker	2.61	Moderate Buy	$22.88	7.21% Upside

Current Analyst Ratings Breakdown

Latest STAA, RXST, EYE, and WRBY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/18/2025	EYE National Vision	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$22.00 ➝ $26.00
5/29/2025	WRBY Warby Parker	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$20.00 ➝ $25.00
5/27/2025	STAA STAAR Surgical	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$20.00
5/22/2025	WRBY Warby Parker	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$18.00 ➝ $21.00
5/21/2025	WRBY Warby Parker	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/21/2025	WRBY Warby Parker	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/21/2025	STAA STAAR Surgical	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/21/2025	WRBY Warby Parker	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$17.00 ➝ $22.00
5/21/2025	WRBY Warby Parker	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$18.00 ➝ $21.00
5/21/2025	WRBY Warby Parker	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $24.00
5/19/2025	EYE National Vision	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Market Perform ➝ Market Perform	$13.00 ➝ $19.00

(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EYE National Vision	$1.82B	1.00	$1.64 per share	14.06	$10.37 per share	2.22
RXST RxSight	$148.31M	3.80	N/A	N/A	$6.98 per share	1.99
STAA STAAR Surgical	$313.90M	2.66	N/A	N/A	$8.06 per share	2.09
WRBY Warby Parker	$771.32M	2.89	$0.34 per share	62.92	$3.35 per share	6.37

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EYE National Vision	-$28.50M	-$0.33	N/A	85.19	6.70	-1.40%	3.44%	1.40%	8/6/2025 (Estimated)
RXST RxSight	-$27.45M	-$0.67	N/A	N/A	N/A	-17.90%	-9.54%	-8.51%	8/4/2025 (Estimated)
STAA STAAR Surgical	-$20.21M	-$1.44	N/A	N/A	N/A	-25.46%	-10.59%	-8.32%	8/6/2025 (Estimated)
WRBY Warby Parker	-$20.39M	-$0.12	N/A	213.37	N/A	-1.79%	-2.48%	-1.29%	8/6/2025 (Estimated)

Latest STAA, RXST, EYE, and WRBY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/7/2025	Q1 2025	EYE National Vision	$0.32	$0.34	+$0.02	$0.18	$510.30 million	$510.32 million
5/7/2025	Q1 2025	RXST RxSight	-$0.03	-$0.03	N/A	-$0.20	$38.74 million	$37.90 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EYE National Vision	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A
STAA STAAR Surgical	N/A	N/A	N/A	N/A	N/A
WRBY Warby Parker	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EYE National Vision	0.29	0.54	0.35
RXST RxSight	N/A	12.68	11.65
STAA STAAR Surgical	N/A	4.78	4.07
WRBY Warby Parker	N/A	2.70	2.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EYE National Vision	N/A
RXST RxSight	78.78%
STAA STAAR Surgical	96.70%
WRBY Warby Parker	93.24%

Insider Ownership

Company	Insider Ownership
EYE National Vision	2.70%
RXST RxSight	9.57%
STAA STAAR Surgical	1.00%
WRBY Warby Parker	18.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EYE National Vision	13,411	79.05 million	76.92 million	Optionable
RXST RxSight	220	40.64 million	36.75 million	Optionable
STAA STAAR Surgical	1,211	49.53 million	49.03 million	Optionable
WRBY Warby Parker	3,780	104.50 million	85.44 million	Optionable

WRBY, RXST, EYE, and STAA Headlines

Recent News About These Companies

Vaughan Nelson Investment Management L.P. Trims Stake in Warby Parker Inc. (NYSE:WRBY)

June 15, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Receives $22.88 Average Price Target from Brokerages

June 14, 2025 | americanbankingnews.com

Tech Giants Partner With Retailers As Smart Glasses Battle Heats Up

June 12, 2025 | forbes.com

Warby Parker eyes space at trendy Raleigh shopping center

June 11, 2025 | bizjournals.com

Warby Parker Inc. (NYSE:WRBY) Given Consensus Rating of "Moderate Buy" by Brokerages

June 11, 2025 | marketbeat.com

WRBY Q1 Earnings Call: Management Details Tariff Mitigation, Store Expansion, and Pricing Actions

June 10, 2025 | msn.com

NBC Securities Inc. Buys 11,574 Shares of Warby Parker Inc. (NYSE:WRBY)

June 9, 2025 | marketbeat.com

Ameriprise Financial Inc. Acquires New Shares in Warby Parker Inc. (NYSE:WRBY)

June 6, 2025 | marketbeat.com

Warby Parker Co-CEO: Google AI Glasses Coming After 2025

June 4, 2025 | pymnts.com

Warby Parker (NYSE:WRBY) Shares Down 3.3% - What's Next?

June 4, 2025 | marketbeat.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $5.29 Million Holdings in Warby Parker Inc. (NYSE:WRBY)

June 3, 2025 | marketbeat.com

Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference

June 2, 2025 | finance.yahoo.com

June 2, 2025 | gurufocus.com

Warby Parker (NYSE:WRBY) Trading Up 3% - Still a Buy?

May 31, 2025 | marketbeat.com

Insider Selling: Warby Parker Inc. (NYSE:WRBY) Director Sells 33,073 Shares of Stock

May 29, 2025 | marketbeat.com

Two Sigma Advisers LP Increases Stake in Warby Parker Inc. (NYSE:WRBY)

May 29, 2025 | marketbeat.com

Google Is Back to Smart Glasses: This Time It Might Work

May 28, 2025 | techopedia.com

Youngme E. Moon Sells 33,073 Shares of Warby Parker Inc. (NYSE:WRBY) Stock

May 28, 2025 | insidertrades.com

Warby Parker Inc. (NYSE:WRBY) Shares Acquired by Two Sigma Investments LP

May 28, 2025 | marketbeat.com

Loop Capital Maintains Buy Rating on Warby Parker (WRBY) Stock

May 27, 2025 | insidermonkey.com

Woodline Partners LP Sells 85,914 Shares of Warby Parker Inc. (NYSE:WRBY)

May 27, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
Analysts Think These Stocks Could More Than Double in Value
By Nathan Reiff | May 23, 2025
View Analysts Think These Stocks Could More Than Double in Value
Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
By Leo Miller | June 18, 2025
View Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
By Gabriel Osorio-Mazilli | June 19, 2025
View Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
ThredUp Stock Reverses on AI Buzz, Eyes Double-Digit Gains
By Thomas Hughes | May 28, 2025
View ThredUp Stock Reverses on AI Buzz, Eyes Double-Digit Gains

WRBY, RXST, EYE, and STAA Company Descriptions

National Vision NASDAQ:EYE

$23.00 +0.64 (+2.86%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$23.00 +0.00 (+0.02%)

As of 06/18/2025 06:14 PM Eastern

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

RxSight NASDAQ:RXST

$13.87 +0.37 (+2.74%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$14.55 +0.68 (+4.90%)

As of 06/18/2025 05:29 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

STAAR Surgical NASDAQ:STAA

$16.85 +0.22 (+1.32%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$16.85 0.00 (0.00%)

As of 06/18/2025 05:10 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Warby Parker NYSE:WRBY

$21.34 -0.49 (-2.26%)

Closing price 06/18/2025 03:59 PM Eastern

Extended Trading

$21.23 -0.11 (-0.50%)

As of 06/18/2025 05:14 PM Eastern

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time